31 March 2016 EMA/333388/2016 Procedure Management and Committees Support

List of nationally authorised medicinal products

Active substance: everolimus (indicated for rejection of transplanted organs)

Procedure no.: PSUSA/00010269/201507

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged.

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

Certican

SE/H/0356/001

35644

Certican

SE/H/0356/002

35665

Certican

SE/H/0356/003

35666

Certican

SE/H/0356/004

35667

Certican

SE/H/0356/005

35668

Certican

SE/H/0356/006

35669

Certican

SE/H/0356/004

088/04704

Certican

SE/H/0356/001

088/04701

Certican

SE/H/0356/002

088/04702

Certican

SE/H/0356/003

088/04703

Certican

SE/H/0356/005

088/04705

SE/H/0356/006

088/04706

SE/H/0356/003

3400936410244

SE/H/0356/003

3400936410305

SE/H/0356/003

3400936410473

SE/H/0356/003

3400956550425

Certican CERTICAN comprimé CERTICAN comprimé CERTICAN comprimé CERTICAN comprimé

0,75 mg 0,75 mg 0,75 mg 0,75 mg

List of nationally authorised medicinal products EMA/333388/2016

MAH of product in the member state NOVARTIS HEALTHCARE A/S (ART57) NOVARTIS HEALTHCARE A/S (ART57) NOVARTIS HEALTHCARE A/S (ART57) NOVARTIS HEALTHCARE A/S (ART57) NOVARTIS HEALTHCARE A/S (ART57) NOVARTIS HEALTHCARE A/S (ART57) NOVARTIS PHARMACEUTICALS UK LIMITED (ART57) NOVARTIS PHARMACEUTICALS UK LIMITED (ART57) NOVARTIS PHARMACEUTICALS UK LIMITED (ART57) NOVARTIS PHARMACEUTICALS UK LIMITED (ART57) NOVARTIS PHARMACEUTICALS UK LIMITED (ART57) NOVARTIS PHARMACEUTICALS UK LIMITED (ART57) NOVARTIS PHARMA S.A.S. (ART57) NOVARTIS PHARMA S.A.S. (ART57) NOVARTIS PHARMA S.A.S. (ART57) NOVARTIS PHARMA S.A.S. (ART57)

Member State where product is authorised DK DK DK DK DK DK MT MT MT MT MT MT FR FR FR FR

Page 2/22

Product Name (in authorisation country) CERTICAN 0,1 mg compresse dispersibili CERTICAN 0,1 mg compresse dispersibili CERTICAN 0,1 mg compresse dispersibili CERTICAN 0,1 mg compresse dispersibili Certican 0,1 mg comprimate pentru dispersie orala Certican 0,1 mg comprimate pentru dispersie orala Certican 0,1 mg comprimate pentru dispersie orala Certican 0,1 mg comprimate pentru dispersie orala Certican 0,1 mg comprimate pentru dispersie orala Certican 0,1 mg comprimate pentru dispersie orala Certican 0,1 mg comprimate pentru dispersie orala Certican 0,1 mg comprimate pentru dispersie orala Certican 0,1 mg Comprimidos dispersíveis

List of nationally authorised medicinal products EMA/333388/2016

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

SE/H/0356/005

036373177

SE/H/0356/005

036373189

SE/H/0356/005

036373191

SE/H/0356/005

036373203

NOVARTIS (ART57) NOVARTIS (ART57) NOVARTIS (ART57) NOVARTIS (ART57)

SE/H/0356/005

7242/2014/01

NOVARTIS PHARMA GMBH (ART57)

RO

SE/H/0356/005

7242/2014/02

NOVARTIS PHARMA GMBH (ART57)

RO

SE/H/0356/005

7242/2014/03

NOVARTIS PHARMA GMBH (ART57)

RO

SE/H/0356/005

7242/2014/04

NOVARTIS PHARMA GMBH (ART57)

RO

not available

6072/2005/01

NOVARTIS PHARMA GMBH (ART57)

RO

not available

6072/2005/02

NOVARTIS PHARMA GMBH (ART57)

RO

not available

6072/2005/03

NOVARTIS PHARMA GMBH (ART57)

RO

not available

6072/2005/04

SE/H/0356/005

5021688

FARMA S.P.A. FARMA S.P.A. FARMA S.P.A. FARMA S.P.A.

NOVARTIS PHARMA GMBH (ART57) NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. ART57

Member State where product is authorised IT IT IT IT

RO

PT

Page 3/22

Product Name (in authorisation country) Certican 0,1 mg dispergeeruvad tabletid Certican 0,1 mg disperģējamās tabletes Certican 0,1 mg dispergerbara tabletter Certican 0,1 mg dispergerbara tabletter Certican 0,1 mg dispergerbare tabletter Certican 0,1 mg dispergovatelne tablety CERTICAN 0,1 mg dispergovatelné tablety Certican 0,1 mg disperguojamosios tabletės Certican 0,1 mg disperguojamosios tabletės Certican 0,1 mg disperguojamosios tabletės Certican 0,1 mg disperguojamosios tabletės Certican 0,1 mg diszpergálódó tabletta Certican 0,1 mg dreifitöflur Certican 0,1 mg tabletki do sporządzania zawiesiny doustnej Certican 0,1 mg Tabletten zur Herstellung einer

List of nationally authorised medicinal products EMA/333388/2016

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

SE/H/0356/005

464305

SE/H/0356/005

05-0030

SE/H/0356/005

18705

SE/H/0356/005

18694

SE/H/0356/005

03-2079

SE/H/0356/005

59/0296/04-S

SE/H/0356/005

59/429/14-C

NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS SVERIGE AB (ART57) NOVARTIS NORGE AS (ART57) NOVARTIS, S.R.O. (ART57) NOVARTIS, S.R.O. (ART57)

SE/H/0356/005

LT/1/05/0321/017

NOVARTIS FINLAND OY (ART57)

LT

SE/H/0356/005

LT/1/05/0321/018

NOVARTIS FINLAND OY (ART57)

LT

SE/H/0356/005

LT/1/05/0321/019

NOVARTIS FINLAND OY (ART57)

LT

SE/H/0356/005

LT/1/05/0321/020

SE/H/0356/005

OGYI-T-9961/05

SE/H/0356/005

IS/1/03/040/05

NOVARTIS FINLAND OY (ART57) NOVARTIS HUNGÁRIA KFT. PHARMA (ART57) NOVARTIS HEALTHCARE A/S (ART57)

SE/H/0356/005

R/22336

NOVARTIS POLAND SP. Z O. O. (ART57)

PL

SE/H/0356/005

BE266454

NOVARTIS PHARMA N.V. (ART57)

BE

EE LV FI SE NO SK CZ

LT HU IS

Page 4/22

Product Name (in authorisation country) Suspension zum Einnehmen Certican 0,1 mg Tabletten zur Herstellung einer Suspension zum Einnehmen Certican 0,1 mg Tabletten zur Herstellung einer Suspension zum Einnehmen CERTICAN 0,1 mg, comprimé dispersible CERTICAN 0,1 mg, comprimé dispersible CERTICAN 0,1 mg, comprimé dispersible CERTICAN 0,1 mg, comprimé dispersible Certican 0,1 mg, comprimés dipsersibles Certican 0,10 mg comprimés dispersibles Certican 0,10 mg dispergeerbare tabletten Certican 0,1mg Tabletten zur Herstellung einer Suspension CERTICAN 0,25 mg compresse CERTICAN 0,25 mg compresse CERTICAN 0,25 mg compresse

List of nationally authorised medicinal products EMA/333388/2016

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

SE/H/0356/005

58387.00.01

NOVARTIS PHARMA GMBH (ART57)

SE/H/0378/005

0010/04030109

SE/H/0356/005

3400936411425

SE/H/0356/005

3400936411593

SE/H/0356/005

3400936411654

SE/H/0356/005

3400956550715

SE/H/0356/005

BE266454

SE/H/0378/005

0010/04030109

SE/H/0356/005

BE266454

SE/H/0356/005

1-25275

SE/H/0356/001

036373013

SE/H/0356/001

036373025

SE/H/0356/001

036373037

NOVARTIS PHARMA (ART57) NOVARTIS PHARMA S.A.S. (ART57) NOVARTIS PHARMA S.A.S. (ART57) NOVARTIS PHARMA S.A.S. (ART57) NOVARTIS PHARMA S.A.S. (ART57) NOVARTIS PHARMA (ART57) NOVARTIS PHARMA (ART57) NOVARTIS PHARMA (ART57)

Member State where product is authorised

DE

N.V.

LU FR FR FR

N.V. N.V. N.V.

NOVARTIS PHARMA GMBH (ART57) NOVARTIS FARMA S.P.A. (ART57) NOVARTIS FARMA S.P.A. (ART57) NOVARTIS FARMA S.P.A. (ART57)

FR BE LU BE

AT IT IT IT

Page 5/22

Product Name (in authorisation country) CERTICAN 0,25 mg compresse CERTICAN 0,25 mg compresse dispersibili CERTICAN 0,25 mg compresse dispersibili CERTICAN 0,25 mg compresse dispersibili CERTICAN 0,25 mg compresse dispersibili Certican 0,25 mg comprimate Certican 0,25 mg comprimate Certican 0,25 mg comprimate Certican 0,25 mg comprimate Certican 0,25 mg comprimate pentru dispersie orală Certican 0,25 mg comprimate pentru dispersie orală Certican 0,25 mg comprimate pentru dispersie orală Certican 0,25 mg comprimate pentru dispersie orală Certican 0,25 mg comprimate/Certican 0,25 mg tablets Certican 0,25 mg comprimate/Certican 0,25 mg tablets

List of nationally authorised medicinal products EMA/333388/2016

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

SE/H/0356/001

036373049

SE/H/0356/006

036373215

SE/H/0356/006

036373227

SE/H/0356/006

036373239

SE/H/0356/006

036373241

not available

6068/2005/01

not available

6068/2005/02

not available

6068/2005/03

not available

6068/2005/04

NOVARTIS FARMA S.P.A. (ART57) NOVARTIS FARMA S.P.A. (ART57) NOVARTIS FARMA S.P.A. (ART57) NOVARTIS FARMA S.P.A. (ART57) NOVARTIS FARMA S.P.A. (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA GMBH (ART57)

not available

6073/2005/01

NOVARTIS PHARMA GMBH (ART57)

RO

not available

6073/2005/02

NOVARTIS PHARMA GMBH (ART57)

RO

not available

6073/2005/03

NOVARTIS PHARMA GMBH (ART57)

RO

not available

6073/2005/04

NOVARTIS PHARMA GMBH (ART57)

RO

SE/H/0356/001

7238/2014/01

NOVARTIS PHARMA GMBH (ART57)

RO

SE/H/0356/001

7238/2014/02

NOVARTIS PHARMA GMBH (ART57)

RO

IT IT IT IT IT RO RO RO RO

Page 6/22

Product Name (in authorisation country) Certican 0,25 mg comprimate/Certican 0,25 mg tablets Certican 0,25 mg comprimate/Certican 0,25 mg tablets Certican 0,25 mg comprimés Certican 0,25 mg comprimés dispersibles Certican 0,25 mg comprimidos dispersíveis Certican 0,25 mg dispergeerbare tabletten Certican 0,25 mg dispergeeruvad tabletid Certican 0,25 mg disperģējamās tabletes Certican 0,25 mg dispergerbara tabletter Certican 0,25 mg dispergerbara tabletter Certican 0,25 mg dispergerbare tabletter Certican 0,25 mg dispergovatelne tablety CERTICAN 0,25 mg dispergovatelné tablety Certican 0,25 mg disperguojamosios tabletės Certican 0,25 mg disperguojamosios tabletės

List of nationally authorised medicinal products EMA/333388/2016

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

SE/H/0356/001

7238/2014/03

NOVARTIS PHARMA GMBH (ART57)

SE/H/0356/001

7238/2014/04

SE/H/0378/001

0010/04030105

SE/H/0356/006

0010/04030110

SE/H/0356/006

5021787

SE/H/0356/006

BE266497

SE/H/0356/006

464205

SE/H/0356/006

05-0031

SE/H/0356/006

18704

SE/H/0356/006

18695

SE/H/0356/006

03-2080

SE/H/0356/006

59/0297/04-S

SE/H/0356/006

59/430/14-C

NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. ART57 NOVARTIS PHARMA N.V. (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS SVERIGE AB (ART57) NOVARTIS NORGE AS (ART57) NOVARTIS, S.R.O. (ART57) NOVARTIS, S.R.O. (ART57)

SE/H/0356/006

LT/1/05/0321/021

NOVARTIS FINLAND OY (ART57)

LT

SE/H/0356/006

LT/1/05/0321/022

NOVARTIS FINLAND OY (ART57)

LT

RO RO LU LU

PT BE EE LV FI SE NO SK CZ

Page 7/22

Product Name (in authorisation country) Certican 0,25 mg disperguojamosios tabletės Certican 0,25 mg disperguojamosios tabletės Certican 0,25 mg diszpergálódó tabletta Certican 0,25 mg dreifitöflur Certican 0,25 mg tablete za oralnu suspenziju Certican 0,25 mg tabletes Certican 0,25 mg tabletid CERTICAN 0,25 MG TABLETKI Certican 0,25 mg tabletki do sporządzania zawiesiny doustnej Certican 0,25 mg tabletta Certican 0,25 mg Tabletten Certican 0,25 mg tabletten Certican 0,25 mg Tabletten Certican 0,25 mg Tabletten Certican 0,25 mg Tabletten zur Herstellung einer Suspension

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

SE/H/0356/006

LT/1/05/0321/023

NOVARTIS FINLAND OY (ART57)

SE/H/0356/006

LT/1/05/0321/024

SE/H/0356/006

OGYI-T-9961/06

SE/H/0356/006

IS/1/03/040/06

SE/H/0356/006

HR-H-996683373

SE/H/0356/001

05-0026

SE/H/0356/001

464705

SE/H/0356/001

R/11215

SE/H/0356/006

R/22337

SE/H/0356/001

OGYI-T-9961/02

SE/H/0356/001

BE266445

SE/H/0356/001

BE266445

SE/H/0356/001

58387.00.00

SE/H/0378/001

0010/04030105

NOVARTIS POLAND SP. Z O. O. (ART57) NOVARTIS HUNGÁRIA KFT. PHARMA (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA N.V. (ART57)

SE/H/0356/006

1-25276

NOVARTIS PHARMA GMBH (ART57)

AT

Certican 0,25 mg

SE/H/0356/006

BE266497

NOVARTIS PHARMA N.V.

BE

List of nationally authorised medicinal products EMA/333388/2016

NOVARTIS FINLAND OY (ART57) NOVARTIS HUNGÁRIA KFT. PHARMA (ART57) NOVARTIS HEALTHCARE A/S (ART57) NOVARTIS HRVATSKA D.O.O. (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS POLAND SP. Z O. O. (ART57)

Member State where product is authorised LT LT HU IS HR LV EE PL PL HU BE BE DE LU

Page 8/22

Product Name (in authorisation country) Tabletten zur Herstellung einer Suspension zum Einnehmen Certican 0,25 mg Tabletten zur Herstellung einer Suspension zum Einnehmen Certican 0,25 mg Tabletten zur Herstellung einer Suspension zum Einnehmen Certican 0,25 mg tabletter Certican 0,25 mg tabletter Certican 0,25 mg tabletter CERTICAN 0,25 mg TABLETY

MRP/DCP Authorisation number

National Authorisation Number

SE/H/0356/006

58387.01.01

SE/H/0356/006

0010/04030110

SE/H/0356/001

18698

SE/H/0356/001

03-2075

SE/H/0356/001

18690

SE/H/0356/001

59/014/05-C

Certican 0,25 mg tablety

SE/H/0356/001

59/0294/04-S

Certican 0,25 mg töflur Certican 0,25 mg, comprimé Certican 0,25 mg, comprimé Certican 0,25 mg, comprimé Certican 0,25 mg, comprimé CERTICAN 0,25 mg, comprimé dispersible

SE/H/0356/001

IS/1/03/040/01

SE/H/0356/001

3400936411074

SE/H/0356/001

3400936411135

SE/H/0356/001

3400936411364

SE/H/0356/001

3400956550654

SE/H/0356/006

3400936411715

List of nationally authorised medicinal products EMA/333388/2016

MAH of product in the member state (ART57)

NOVARTIS PHARMA GMBH (ART57)

NOVARTIS PHARMA N.V. (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS NORGE AS (ART57) NOVARTIS SVERIGE AB (ART57) NOVARTIS, S.R.O. (ART57) NOVARTIS, S.R.O. (ART57) NOVARTIS HEALTHCARE A/S (ART57) NOVARTIS PHARMA S.A.S. (ART57) NOVARTIS PHARMA S.A.S. (ART57) NOVARTIS PHARMA S.A.S. (ART57) NOVARTIS PHARMA S.A.S. (ART57) NOVARTIS PHARMA S.A.S. (ART57)

Member State where product is authorised

DE

LU FI NO SE CZ SK IS FR FR FR FR FR

Page 9/22

Product Name (in authorisation country) CERTICAN 0,25 mg, comprimé dispersible CERTICAN 0,25 mg, comprimé dispersible CERTICAN 0,25 mg, comprimé dispersible Certican 0,25 mg, comprimés Certican 0,25 mg, comprimés dipsersibles

MRP/DCP Authorisation number

National Authorisation Number

SE/H/0356/006

3400936411883

SE/H/0356/006

3400936411944

SE/H/0356/006

3400956550883

SE/H/0356/001

BE266445

SE/H/0356/006

BE266497

Certican 0,25 tabletės

SE/H/0356/001

LT/1/05/0321/001

Certican 0,25 tabletės

SE/H/0356/001

LT/1/05/0321/002

Certican 0,25 tabletės

SE/H/0356/001

LT/1/05/0321/003

Certican 0,25 tabletės Certican 0,25 tabletten 0,25 mg Certican 0,25mg comprimate pentru dispersie orala Certican 0,25mg comprimate pentru dispersie orala Certican 0,25mg comprimate pentru dispersie orala Certican 0,25mg comprimate pentru dispersie orala

SE/H/0356/001

LT/1/05/0321/004

SE/H/0356/001

RVG 30041

NOVARTIS PHARMA S.A.S. (ART57) NOVARTIS PHARMA S.A.S. (ART57) NOVARTIS PHARMA S.A.S. (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS PHARMA B.V. (ART57)

SE/H/0356/006

7243/2014/01

NOVARTIS PHARMA GMBH (ART57)

RO

SE/H/0356/006

7243/2014/02

NOVARTIS PHARMA GMBH (ART57)

RO

SE/H/0356/006

7243/2014/03

NOVARTIS PHARMA GMBH (ART57)

RO

SE/H/0356/006

7243/2014/04

SE/H/0356/001

5021282

Certican 0,25mg comprimidos

List of nationally authorised medicinal products EMA/333388/2016

MAH of product in the member state

NOVARTIS PHARMA GMBH (ART57) NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. ART57

Member State where product is authorised FR FR FR BE BE LT LT LT LT NL

RO

PT

Page 10/22

Product Name (in authorisation country) Certican 0,25mg Tabletten Certican 0,5 mg compresse CERTICAN 0,5 mg compresse CERTICAN 0,5 mg compresse CERTICAN 0,5 mg compresse Certican 0,5 mg comprimate Certican 0,5 mg comprimate Certican 0,5 mg comprimate Certican 0,5 mg comprimate Certican 0,5 mg comprimate/certican tablets Certican 0,5 mg comprimate/certican tablets Certican 0,5 mg comprimate/certican tablets Certican 0,5 mg comprimate/certican tablets Certican 0,5 mg comprimés

0,5 0,5 0,5 0,5

Certican 0,5 mg Comprimidos

List of nationally authorised medicinal products EMA/333388/2016

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

SE/H/0356/001

1-25271

SE/H/0356/002

036373052

SE/H/0356/002

036373064

SE/H/0356/002

036373076

SE/H/0356/002

036373088

not available

6069/2005/01

not available

6069/2005/02

not available

6069/2005/03

not available

6069/2005/04

NOVARTIS PHARMA GMBH (ART57) NOVARTIS FARMA S.P.A. (ART57) NOVARTIS FARMA S.P.A. (ART57) NOVARTIS FARMA S.P.A. (ART57) NOVARTIS FARMA S.P.A. (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA GMBH (ART57)

SE/H/0356/002

7239/2014/01

NOVARTIS PHARMA GMBH (ART57)

RO

SE/H/0356/002

7239/2014/02

NOVARTIS PHARMA GMBH (ART57)

RO

SE/H/0356/002

7239/2014/03

NOVARTIS PHARMA GMBH (ART57)

RO

SE/H/0356/002

7239/2014/04

SE/H/0378/002

0010/04030106

SE/H/0356/002

5021381

NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. ART57

Member State where product is authorised AT IT IT IT IT RO RO RO RO

RO LU

PT

Page 11/22

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

Certican 0,5 mg tablete

not available

UP/I-530-09/11-02/196

Certican 0,5 mg tabletes

SE/H/0356/002

05-0027

Certican 0,5 mg tabletės

SE/H/0356/002

LT/1/05/0321/005

Certican 0,5 mg tabletės

SE/H/0356/002

LT/1/05/0321/006

Certican 0,5 mg tabletės

SE/H/0356/002

LT/1/05/0321/007

Certican 0,5 mg tabletės

SE/H/0356/002

LT/1/05/0321/008

Certican 0,5 mg tabletid CERTICAN 0,5 MG TABLETKI

SE/H/0356/002

464605

SE/H/0356/002

R/11214

Certican 0,5 Certican 0,5 Tabletten Certican 0,5 Tabletten Certican 0,5 Tabletten Certican 0,5 tabletter Certican 0,5 tabletter Certican 0,5 tabletter

SE/H/0356/002

OGYI-T-9961/01

SE/H/0356/002

BE266481

SE/H/0356/002

58387.01.00

SE/H/0378/002

0010/04030106

SE/H/0356/002

18699

SE/H/0356/002

03-2076

SE/H/0356/002

18691

Certican 0,5 mg tablety

SE/H/0356/002

59/428/14-C

Certican 0,5 mg tablety

SE/H/0356/002

59/0295/04-S

Certican 0,5 mg töflur

SE/H/0356/002

IS/1/03/040/02

mg tabletta mg mg mg mg mg mg

List of nationally authorised medicinal products EMA/333388/2016

MAH of product in the member state NOVARTIS HRVATSKA D.O.O. (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS POLAND SP. Z O. O. (ART57) NOVARTIS HUNGÁRIA KFT. PHARMA (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS NORGE AS (ART57) NOVARTIS SVERIGE AB (ART57) NOVARTIS, S.R.O. (ART57) NOVARTIS, S.R.O. (ART57) NOVARTIS HEALTHCARE A/S (ART57)

Member State where product is authorised HR LV LT LT LT LT EE PL HU BE DE LU FI NO SE CZ SK IS

Page 12/22

Product Name (in authorisation country) CERTICAN 0,5 mg, comprimé CERTICAN 0,5 mg, comprimé CERTICAN 0,5 mg, comprimé CERTICAN 0,5 mg, comprimé Certican 0,5 mg, comprimés Certican 0,5 tabletten 0,5 mg Certican 0,50 mg Tabletten Certican 0,50 mg tabletten Certican 0,75 mg Tabletten Certican 0,75 mg compresse Certican 0,75 mg compresse Certican 0,75 mg compresse Certican 0,75 mg compresse Certican 0,75 mg comprimate Certican 0,75 mg comprimate Certican 0,75 mg comprimate Certican 0,75 mg comprimate Certican 0,75 mg comprimate/Certican

List of nationally authorised medicinal products EMA/333388/2016

MRP/DCP Authorisation number

National Authorisation Number

SE/H/0356/002

3400936410763

SE/H/0356/002

3400936410824

SE/H/0356/002

3400936410992

SE/H/0356/002

3400956550593

SE/H/0356/002

BE266481

SE/H/0356/002

RVG 30042

SE/H/0356/002

1-25272

SE/H/0356/002

BE266481

SE/H/0356/003

1-25273

SE/H/0356/003

036373090

SE/H/0356/003

036373102

SE/H/0356/003

036373114

SE/H/0356/003

036373126

not available

6070/2005/01

not available

6070/2005/02

not available

6070/2005/03

not available

6070/2005/04

SE/H/0356/003

7240/2014/01

MAH of product in the member state NOVARTIS PHARMA S.A.S. (ART57) NOVARTIS PHARMA S.A.S. (ART57) NOVARTIS PHARMA S.A.S. (ART57) NOVARTIS PHARMA S.A.S. (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS PHARMA B.V. (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS FARMA S.P.A. (ART57) NOVARTIS FARMA S.P.A. (ART57) NOVARTIS FARMA S.P.A. (ART57) NOVARTIS FARMA S.P.A. (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA GMBH (ART57)

Member State where product is authorised FR FR FR FR BE NL AT BE AT IT IT IT IT RO RO RO RO RO

Page 13/22

Product Name (in authorisation country) 0,75 mg tablets Certican 0,75 mg comprimate/Certican 0,75 mg tablets Certican 0,75 mg comprimate/Certican 0,75 mg tablets Certican 0,75 mg comprimate/Certican 0,75 mg tablets Certican 0,75 mg Comprimidos Certican 0,75 mg tabletes Certican 0,75 mg tabletid CERTICAN 0,75 MG TABLETKI Certican 0,75 mg tabletta Certican 0,75 mg Tabletten Certican 0,75 mg tabletten Certican 0,75 mg Tabletten Certican 0,75 mg Tabletten Certican 0,75 mg tabletten 0,75 mg Certican 0,75 mg tabletter Certican 0,75 mg tabletter List of nationally authorised medicinal products EMA/333388/2016

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

SE/H/0356/003

7240/2014/02

NOVARTIS PHARMA GMBH (ART57)

RO

SE/H/0356/003

7240/2014/03

NOVARTIS PHARMA GMBH (ART57)

RO

SE/H/0356/003

7240/2014/04

SE/H/0356/003

5021480

SE/H/0356/003

05-0028

SE/H/0356/003

464505

SE/H/0356/003

R/11226

SE/H/0356/003

OGYI-T-9961/03

SE/H/0356/003

BE266472

SE/H/0356/003

BE266472

SE/H/0356/003

58387.02.00

SE/H/0378/003

0010/04030107

SE/H/0356/003

RVG 30043

SE/H/0356/003

18702

SE/H/0356/003

03-2077

NOVARTIS PHARMA GMBH (ART57) NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. ART57 NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS POLAND SP. Z O. O. (ART57) NOVARTIS HUNGÁRIA KFT. PHARMA (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS PHARMA B.V. (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS NORGE AS (ART57)

Member State where product is authorised

RO

PT LV EE PL HU BE BE DE LU NL FI NO

Page 14/22

Product Name (in authorisation country) Certican 0,75 mg tabletter CERTICAN 0,75 mg TABLETY

MRP/DCP Authorisation number

National Authorisation Number

SE/H/0356/003

18692

SE/H/0356/003

59/016/05-C

Certican 0,75 mg töflur Certican 0,75 mg, comprimés

SE/H/0356/003

IS/1/03/040/03

SE/H/0356/003

BE266472

Certican 0,75 tabletės

SE/H/0356/003

LT/1/05/0321/009

Certican 0,75 tabletės

SE/H/0356/003

LT/1/05/0321/010

Certican 0,75 tabletės

SE/H/0356/003

LT/1/05/0321/011

Certican 0,75 tabletės Certican 0,75mg comprimés CERTICAN 0.1 mg comprimidos dispersables Certican 0.1 mg dispergoituva tabletti

SE/H/0356/003

LT/1/05/0321/012

SE/H/0378/003

0010/04030107

SE/H/0356/005

66009

SE/H/0356/005

18705

SE/H/0378/005

PA 13/124/005

SE/H/0356/005

PL 00101/0965

SE/H/0356/005

H/05/00370/001

SE/H/0356/005

H/05/00370/002

SE/H/0356/005

HR-H-542458362

NOVARTIS SVERIGE AB (ART57) NOVARTIS, S.R.O. (ART57) NOVARTIS HEALTHCARE A/S (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS FARMACÉUTICA S.A. (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS PHARMACEUTICALS UK LIMITED (ART57) NOVARTIS PHARMACEUTICALS UK LIMITED (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS HRVATSKA D.O.O. (ART57)

SE/H/0356/001

66001

NOVARTIS

Certican 0.1 mg dispersible tablets Certican 0.1 mg dispersible tablets Certican 0.1 mg disperzibilne tablete Certican 0.1 mg disperzibilne tablete Certican 0.1 mg tablete za oralnu suspenziju CERTICAN 0.25 mg List of nationally authorised medicinal products EMA/333388/2016

MAH of product in the member state

Member State where product is authorised SE CZ IS BE LT LT LT LT LU ES FI IE UK SI SI HR ES

Page 15/22

Product Name (in authorisation country) comprimidos

MRP/DCP Authorisation number

National Authorisation Number

SE/H/0356/006

66002

SE/H/0356/006

18704

SE/H/0356/006

PA 13/124/006

SE/H/0356/006

PL 00101/0966

SE/H/0356/006 SE/H/0356/006

H/05/00370/005 5363-I-1011/09 H/05/00370/006

Certican 0.25 mg tablete

SE/H/0356/001

HR-H-809985014

Certican 0.25 mg tablete

SE/H/0356/001

H/05/00370/009

Certican 0.25 mg tablete

SE/H/0356/001

H/05/00370/010

Certican 0.25 mg tablets

SE/H/0378/001

PA 13/124/001

Certican 0.25 mg tablets

SE/H/0356/001

PL 00101/0961

Certican 0.25 mg tabletti

SE/H/0356/001

18698

Certican 0.5 mg tablete

SE/H/0356/002

HR-H-592546271

Certican 0.5 mg tablete

SE/H/0356/002

H/05/00370/013

FARMACÉUTICA S.A. (ART57) NOVARTIS FARMACÉUTICA S.A. (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS PHARMACEUTICALS UK LIMITED (ART57) NOVARTIS PHARMACEUTICALS UK LIMITED (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS HRVATSKA D.O.O. (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMACEUTICALS UK LIMITED (ART57) NOVARTIS PHARMACEUTICALS UK LIMITED (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS HRVATSKA D.O.O. (ART57) NOVARTIS PHARMA GMBH (ART57)

Certican 0.5 mg tablete

SE/H/0356/002

H/05/00370/014

NOVARTIS PHARMA

CERTICAN 0.25 mg comprimidos dispersables Certican 0.25 mg dispergoituva tabletti Certican 0.25 mg dispersible tablets Certican 0.25 mg dispersible tablets Certican 0.25 mg disperzibilne tablete Certican 0.25 mg disperzibilne tablete

List of nationally authorised medicinal products EMA/333388/2016

MAH of product in the member state

Member State where product is authorised

ES FI IE UK SI SI HR SI SI IE UK FI HR SI SI

Page 16/22

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state GMBH (ART57)

Certican 0.5 mg tablets

SE/H/0378/002

PA 13/124/002

Certican 0.5 mg tablets

SE/H/0356/002

PL 00101/0962

Certican 0.5 mg tabletti

SE/H/0356/002

18699

CERTICAN 0.50 mg comprimidos

SE/H/0356/002

66006

CERTICAN 0.75 mg comprimidos

SE/H/0356/003

66007

Certican 0.75 mg tablete

SE/H/0356/003

HR-H-941540378

Certican 0.75 mg tablete

SE/H/0356/003

H/05/00370/017

Certican 0.75 mg tablete

SE/H/0356/003

H/05/00370/018

Certican 0.75 mg tablets

SE/H/0378/003

PA 13/124/003

Certican 0.75 mg tablets

SE/H/0356/003

PL 00101/0963

Certican 0.75 mg tabletti Certican 1 mg comprimate Certican 1 mg comprimate Certican 1 mg comprimate

SE/H/0356/003

18702

not available

6071/2005/01

not available

6071/2005/02

not available

6071/2005/03

NOVARTIS PHARMACEUTICALS UK LIMITED (ART57) NOVARTIS PHARMACEUTICALS UK LIMITED (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FARMACÉUTICA S.A. (ART57) NOVARTIS FARMACÉUTICA S.A. (ART57) NOVARTIS HRVATSKA D.O.O. (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMACEUTICALS UK LIMITED (ART57) NOVARTIS PHARMACEUTICALS UK LIMITED (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA GMBH (ART57)

Certican 1 mg

not available

6071/2005/04

NOVARTIS PHARMA

List of nationally authorised medicinal products EMA/333388/2016

Member State where product is authorised

IE UK FI ES ES HR SI SI IE UK FI RO RO RO RO

Page 17/22

Product Name (in authorisation country) comprimate

MRP/DCP Authorisation number

National Authorisation Number

SE/H/0356/004

7241/2014/01

NOVARTIS PHARMA GMBH (ART57)

RO

SE/H/0356/004

7241/2014/02

NOVARTIS PHARMA GMBH (ART57)

RO

SE/H/0356/004

7241/2014/03

NOVARTIS PHARMA GMBH (ART57)

RO

SE/H/0356/004

7241/2014/04

SE/H/0378/004

0010/04030108

Certican 1 mg Comprimidos

SE/H/0356/004

5021589

Certican 1 mg tabletes

SE/H/0356/004

05-0029

Certican 1 mg tabletės

SE/H/0356/004

LT/1/05/0321/013

Certican 1 mg tabletės

SE/H/0356/004

LT/1/05/0321/014

Certican 1 mg tabletės

SE/H/0356/004

LT/1/05/0321/015

Certican 1 mg tabletės

SE/H/0356/004

LT/1/05/0321/016

Certican 1 mg tabletten

SE/H/0356/004

BE266463

Certican 1 mg tabletter CERTICAN 1 mg TABLETY

SE/H/0356/004

18693

SE/H/0356/004

59/017/05-C

NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS FARMA PRODUTOS FARMACÊUTICOS S.A. ART57 NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS SVERIGE AB (ART57) NOVARTIS, S.R.O. (ART57)

Certican 1,0 mg

SE/H/0356/004

036373138

NOVARTIS FARMA S.P.A.

Certican 1 mg comprimate/certican mg tablets Certican 1 mg comprimate/certican mg tablets Certican 1 mg comprimate/certican mg tablets Certican 1 mg comprimate/certican mg tablets Certican 1 mg comprimés

1 1 1 1

List of nationally authorised medicinal products EMA/333388/2016

MAH of product in the member state GMBH (ART57)

Member State where product is authorised

RO LU

PT LV LT LT LT LT BE SE CZ IT

Page 18/22

Product Name (in authorisation country) compresse

MRP/DCP Authorisation number

National Authorisation Number

SE/H/0356/004

036373140

SE/H/0356/004

036373153

SE/H/0356/004

036373165

Certican 1,0 mg tabletid

SE/H/0356/004

464405

Certican 1,0 Certican 1,0 Tabletten Certican 1,0 Tabletten Certican 1,0 Tabletten Certican 1,0 tabletter Certican 1,0 tabletter

SE/H/0356/004

OGYI-T-9961/04

SE/H/0356/004

BE266463

SE/H/0356/004

58387.03.00

SE/H/0378/004

0010/04030108

SE/H/0356/004

18703

SE/H/0356/004

03-2078

Certican 1,0 mg tablety

SE/H/0356/004

59/0299/04-S

Certican 1,0 mg töflur. Certican 1,0 mg, comprimés

SE/H/0356/004

IS/1/03/040/04

SE/H/0356/004

BE266463

Certican 1,0 mg, tabletki Certican 1,0 tabletten 1,0 mg

SE/H/0356/004

R/22335

SE/H/0356/004

RVG 30044

Certican 1.0 mg tabletti

SE/H/0356/004

18703

CERTICAN 1.0 mg comprimidos

SE/H/0356/004

66008

Certican 1,0 mg compresse Certican 1,0 mg compresse Certican 1,0 mg compresse

mg tabletta mg mg mg mg mg

List of nationally authorised medicinal products EMA/333388/2016

MAH of product in the member state (ART57) NOVARTIS FARMA S.P.A. (ART57) NOVARTIS FARMA S.P.A. (ART57) NOVARTIS FARMA S.P.A. (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS HUNGÁRIA KFT. PHARMA (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS NORGE AS (ART57) NOVARTIS, S.R.O. (ART57) NOVARTIS HEALTHCARE A/S (ART57) NOVARTIS PHARMA N.V. (ART57) NOVARTIS POLAND SP. Z O. O. (ART57) NOVARTIS PHARMA B.V. (ART57) NOVARTIS FINLAND OY (ART57) NOVARTIS FARMACÉUTICA S.A. (ART57)

Member State where product is authorised

IT IT IT EE HU BE DE LU FI NO SK IS BE PL NL FI ES

Page 19/22

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

Certican 1.0 mg tablete

SE/H/0356/004

HR-H-694937531

Certican 1.0 mg tablete

SE/H/0356/004

H/05/00370/021

Certican 1.0 mg tablete

SE/H/0356/004

H/05/00370/022

Certican 1.0 mg tablets

SE/H/0356/004

PA 13/124/004

Certican 1.0mg tablets

SE/H/0356/004

PL 00101/0964

Certican 1mg - Tabletten Certican Dispers 0,1, dispergeerbare tabletten 0,1 mg Certican Dispers 0,25, dispergeerbare tabletten 0,25 mg

SE/H/0356/004

1-25274

NOVARTIS HRVATSKA D.O.O. (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMA GMBH (ART57) NOVARTIS PHARMACEUTICALS UK LIMITED (ART57) NOVARTIS PHARMACEUTICALS UK LIMITED (ART57) NOVARTIS PHARMA GMBH (ART57)

SE/H/0356/005

RVG 30045

NOVARTIS PHARMA B.V. (ART57)

SE/H/0356/006

RVG 30046

Certican διασπειρόμενα δισκία 0.1mg

SE/H/0356/005

19646

Certican διασπειρόμενα δισκία 0.25mg

SE/H/0356/006

19647

Certican δισκία 0.75mg

SE/H/0356/003

19644

Certican δισκία 0,25mg

SE/H/0356/001

19642

Certican δισκία 0.5mg

SE/H/0356/002

19643

NOVARTIS PHARMA (ART57) NOVARTIS PHARMACEUTICALS LIMITED (ART57) NOVARTIS PHARMACEUTICALS LIMITED (ART57) NOVARTIS PHARMACEUTICALS LIMITED (ART57) NOVARTIS PHARMACEUTICALS LIMITED (ART57) NOVARTIS PHARMACEUTICALS LIMITED (ART57)

Certican δισκία 1mg

SE/H/0356/004

19645

NOVARTIS

List of nationally authorised medicinal products EMA/333388/2016

MAH of product in the member state

B.V. UK UK UK UK UK

Member State where product is authorised HR SI SI IE UK AT NL NL CY CY CY CY CY CY

Page 20/22

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

SE/H/0378/005

261570501

SE/H/0378/005

261570502

SE/H/0378/005

261570503

SE/H/0378/005

261570504

SE/H/0356/006

261570601

SE/H/0356/006

261570602

SE/H/0356/006

261570603

SE/H/0356/006

261570604

Certican, δισκίο 0.25mg

SE/H/0378/001

261570101

Certican, δισκίο 0.25mg

SE/H/0378/001

261570102

Certican, δισκίο 0.25mg

SE/H/0378/001

261570103

Certican, δισκίο 0.25mg

SE/H/0378/001

261570104

Certican, δισκίο 0.5mg

SE/H/0378/002

261570201

Certican, δισκίο 0.5mg

SE/H/0378/002

261570202

Certican, δισκίο 0.5mg

SE/H/0378/002

261570203

Certican, δισκίο 0.5mg

SE/H/0378/002

261570204

Certican, δισκίο 0.75mg

SE/H/0378/003

261570301

Certican, διασπειρόμενο δισκίο 0.1mg Certican, διασπειρόμενο δισκίο 0.1mg Certican, διασπειρόμενο δισκίο 0.1mg Certican, διασπειρόμενο δισκίο 0.1mg Certican, διασπειρόμενο δισκίο 0.25mg Certican, διασπειρόμενο δισκίο 0.25mg Certican, διασπειρόμενο δισκίο 0.25mg Certican, διασπειρόμενο δισκίο 0.25mg

List of nationally authorised medicinal products EMA/333388/2016

MAH of product in the member state PHARMACEUTICALS UK LIMITED (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57)

Member State where product is authorised

GR GR GR GR GR GR GR GR GR GR GR GR GR GR GR GR GR

Page 21/22

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

Certican, δισκίο 0.75mg

SE/H/0378/003

261570302

Certican, δισκίο 0.75mg

SE/H/0378/003

261570303

Certican, δισκίο 0.75mg

SE/H/0378/003

261570304

Certican, δισκίο 1mg

SE/H/0378/004

261570401

Certican, δισκίο 1mg

SE/H/0378/004

261570402

Certican, δισκίο 1mg

SE/H/0378/004

261570403

Certican, δισκίο 1mg

SE/H/0378/004

261570404

Certican0,75 mg tbl Everolimus Novartis mg dispergerbara tabletter Everolimus Novartis mg dispergerbara tabletter Everolimus Novartis mg tabletter Everolimus Novartis mg tabletter Everolimus Novartis mg tabletter Everolimus Novartis mg tabletter

0,1

SE/H/0356/003 SE/H/378/005

59/0298/04-S

0,25

SE/H/378/006

0,25

NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS (HELLAS) S.A.C.I. (ART57) NOVARTIS, S.R.O. (ART57) NOVARTIS SVERIGE AB

Member State where product is authorised GR GR GR GR GR GR GR SK SE

NOVARTIS SVERIGE AB

SE

19842

NOVARTIS SVERIGE AB

19843

NOVARTIS SVERIGE AB NOVARTIS SVERIGE AB

SE SE

19847

0,5

SE/H/378/001 SE/H/378/002

0,75

SE/H/378/003

1

SE/H/378/004

List of nationally authorised medicinal products EMA/333388/2016

19846

MAH of product in the member state

19844 19845

NOVARTIS SVERIGE AB

SE SE

Page 22/22

everolimus (indicated for rejection of transplanted organs) - European ...

Mar 31, 2016 - An agency of the European Union. Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our website ...

258KB Sizes 0 Downloads 161 Views

Recommend Documents

everolimus - European Medicines Agency - Europa EU
Mar 31, 2016 - Procedure Management and Committees Support. List of nationally ...... LIMITED (ART57). UK. Certican 0.25 mg tabletti SE/H/0356/001. 18698.

Automatic segmentation of the thoracic organs for ...
and another with the lungs, the heart and the rest soft tissues is achieved by ..... These scans can detect smaller lung tumors than a conventional CT scan and the ex- amination takes only a few minutes. • With bronchoscopy, a careful examination o

nitrogen management strategies for transplanted rice
2000; Balasubramanian et al. 2000) to economise the fertiliser N. A field experiment in this line was conducted during rabi 1997-98 crop season in Noyal series.

Rejection of persistent bounded disturbances - Semantic Scholar
compensation does not improve the optimal rejection of finite-energy (i.e., £ 2) disturbances. .... solutions which gives the same value at k = O. [] .... One alternative is to consider the worst case performance over a given class of disturbances.

Publication rejection among ecologists
It is widely recognized that anyone pursuing a career in the arts needs a thick skin to cope with the frequent rejection that they face on the path to career success.

anatomical variability of organs via principal factor ...
degrees of freedom in the transformation, the bias from the reference data is minimized, in terms of organ shape, size and position. ..... Mapping (ICBM).

Rejection and valuations
Mar 30, 2009 - We can define validity more snappily, if we help ourselves to a bit of ... hyper-valuation which makes the premisses true and conclusion false, ...

Rejection and valuations - Logic Matters
Mar 30, 2009 - of themes from that paper, though done in our own way, and then considers a putative line of objection – recently advanced by Julien Murzi and ...

Rejection and valuations - Logic Matters
Mar 30, 2009 - of themes from that paper, though done in our own way, and then considers a putative line of objection – recently advanced by Julien Murzi and Ole ... Greek letters indicate whole signed sentences and ∗α be the result of ...

Dempster-Shafer based rejection strategy for handwritten word ...
is defined on the powerset of Ω, noted P(Ω) and it maps onto [0, 1] so that ... bound of the subjective probabilities which are consistent with the available evidence. Dually, the plausibility function pl is defined by : pl (A) = ∑. B∩A=∅ m (

The Variability of Organs Differentially Involved in ...
respectively. Standard and keel petal size varied in parallel, not only in conspecific individuals but also across species .... massively in winter or early spring.

Asymptotic Disturbance Rejection for the TORA System ...
Jul 13, 2009 - Department of Computer and Systems Science Antonio Ruberti. Sapienza University of Rome. Italy. IASTED Conference on Control and ...

Spacing and weed management in transplanted ...
at 6 DAT supplemented with hand weeding at 20 DAT and anilofos+2,4-DEE. (readymix) 0.40+0.53 kg ha-1 at 6 DAT supplemented with 2,4-D sodium salt 1 kg ha-1 at 20 DAT). Grasses were the predominant weed species observed in the experimental field. Unch

Costly rejection of wrongdoers by infants and children.pdf ...
Costly rejection of wrongdoers by infants and children.pdf. Costly rejection of wrongdoers by infants and children.pdf. Open. Extract. Open with. Sign In.

Conversion to Everolimus in Kidney Transplant ...
recipients with respect to the procedure of conversion, initial doses, and target ... with rapamycin conversion in stable renal transplant recip- .... Laboratory Data.

Active Disturbance Rejection Control of a 2DOF ...
considered 2DOF manipulator lead to an increase of the kinetic energy during the ... acting disturbances, the ADRC method is an alternative that significantly ..... of path following, trajectory tracking, and energy efficiency (in means of control.